Related Experiment Videos
Antimetabolites in the surgical treatment of glaucomas
R Van Oye1, E Van Caelenberghe
1University Hospital of Ghent, Department of Ophthalmology, Belgium.
Bulletin De La Societe Belge D'Ophtalmologie
|January 1, 1992
Abstract:
Fibroblast proliferation with scarring at the surgical site plays an important role in the failure of filtration surgery. Several antimetabolites inhibit fibroblast proliferation in vitro. These observations have lead to the widespread clinical use in humans of 5-fluorouracil and more recently mitomycin-C in glaucoma filtering surgery.
Insights
Fibroblast proliferation causes scarring and filtration surgery failure. Antimetabolites like 5-fluorouracil and mitomycin-C are used to inhibit this proliferation in glaucoma surgery.
Area of Science:
- Ophthalmology
- Surgical Science
- Cell Biology
Background:
- Fibroblast proliferation and subsequent scarring at surgical sites are key factors in filtration surgery failure.
- Antimetabolites have demonstrated in vitro efficacy in inhibiting fibroblast proliferation.
Purpose of the Study:
- To review the role of fibroblast proliferation in filtration surgery outcomes.
- To discuss the clinical application of antimetabolites in glaucoma surgery.
Main Methods:
- Literature review of studies on fibroblast proliferation and antimetabolite efficacy.
- Analysis of clinical data regarding the use of 5-fluorouracil and mitomycin-C in glaucoma filtering surgery.
Main Results:
- Fibroblast proliferation is a significant contributor to surgical site scarring and failure.
- 5-fluorouracil and mitomycin-C have been adopted for clinical use due to their inhibitory effects on fibroblast proliferation.
Conclusions:
- Inhibiting fibroblast proliferation is a viable strategy to improve glaucoma filtering surgery success rates.
- Antimetabolites represent an important therapeutic option for managing fibroblast-mediated complications in ophthalmic surgery.